37978-59-9 Usage
Uses
Used in Pharmaceutical Industry:
(E)-3-(Methoxycarbonyl)-4-(5-methylfuran-2-yl)but-3-enoic acid is used as a potential pharmaceutical agent due to its unique molecular structure and the presence of functional groups that are often found in biologically active compounds. Its potential applications may include the development of new drugs targeting various diseases, given the compound's capacity to interact with biological systems.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (E)-3-(Methoxycarbonyl)-4-(5-methylfuran-2-yl)but-3-enoic acid serves as a subject of study for understanding its interactions with biological targets and its potential therapeutic effects. Researchers may investigate its binding affinity, selectivity, and mechanism of action to optimize its properties for specific medical applications.
Used in Drug Development:
(E)-3-(Methoxycarbonyl)-4-(5-methylfuran-2-yl)but-3-enoic acid is utilized in drug development processes to create novel therapeutic agents. Its unique structure and functional groups can be further modified or used as a template for designing new molecules with improved pharmacological properties, such as enhanced potency, selectivity, and reduced side effects.
Check Digit Verification of cas no
The CAS Registry Mumber 37978-59-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,9,7 and 8 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 37978-59:
(7*3)+(6*7)+(5*9)+(4*7)+(3*8)+(2*5)+(1*9)=179
179 % 10 = 9
So 37978-59-9 is a valid CAS Registry Number.
InChI:InChI=1/C11H12O5/c1-7-3-4-9(16-7)5-8(6-10(12)13)11(14)15-2/h3-5H,6H2,1-2H3,(H,12,13)/b8-5+
37978-59-9Relevant academic research and scientific papers
BENZOFURAN DERIVATES, PROCESS FOR THEIR PREPARATION AND INTERMEDIATES THEREOF
-
Page 27, (2010/02/07)
Compound of formula (I) wherein A is selected from pyridin-2-yl or thiazol-2-yl and R1, R2 and R3 are as described in the specification and their use in the treatment or prevention of a disease or medical conditions mediated through glucokinase.
